Plozasiran (ARO-APOC3) for severe hypertriglyceridemia: the SHASTA-2 randomized clinical trial
D Gaudet, D Pall, GF Watts, SJ Nicholls… - JAMA …, 2024 - jamanetwork.com
Importance Severe hypertriglyceridemia (sHTG) confers increased risk of atherosclerotic
cardiovascular disease (ASCVD), nonalcoholic steatohepatitis, and acute pancreatitis …
cardiovascular disease (ASCVD), nonalcoholic steatohepatitis, and acute pancreatitis …
Precision Medicine Approaches to Vascular Disease: JACC Focus Seminar 2/5
In this second of a 5-part Focus Seminar series, we focus on precision medicine in the
context of vascular disease. The most common vascular disease worldwide is …
context of vascular disease. The most common vascular disease worldwide is …
[HTML][HTML] The impact of lipid-lowering medications on coronary artery plaque characteristics
VP Pulipati, FJ Alenghat - American Journal of Preventive Cardiology, 2021 - Elsevier
Atherosclerosis is the predominant cause of coronary artery disease. The last several
decades have witnessed significant advances in lipid-lowering therapies, which comprise a …
decades have witnessed significant advances in lipid-lowering therapies, which comprise a …
Increased cellular uptake of polyunsaturated fatty acids and phytosterols from natural micellar oil
C Röhrl, F Stübl, M Maier, B Schwarzinger… - Nutrients, 2020 - mdpi.com
The transport of hydrophobic compounds to recipient cells is a critical step in nutrient
supplementation. Here, we tested the effect of phospholipid-based emulsification on the …
supplementation. Here, we tested the effect of phospholipid-based emulsification on the …
[HTML][HTML] Recent updates in dyslipidemia management: perspectives in stroke-specific situation
Managing dyslipidemia in stroke is essential. During the past several decades, monumental
changes in dyslipidemia management have occurred, resulting in improvement in outcomes …
changes in dyslipidemia management have occurred, resulting in improvement in outcomes …
A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy
Cardiovascular diseases associated with high cholesterol (hypercholesterolemia) and low-
density lipoproteins (LDL) levels are significant contributors to total mortality in develo** …
density lipoproteins (LDL) levels are significant contributors to total mortality in develo** …
Hipertrigliceridemia: clasificación, riesgo cardiovascular y conducta terapéutica
SNG Benítez, GEF Díaz, RCV Cabodevilla… - Correo Científico …, 2020 - revcocmed.sld.cu
La hipertrigliceridemia es una afección común, debida a alteraciones genéticas o primarias
y secundarias a enfermedades o medicamentos. Su causa principal es el estilo de vida no …
y secundarias a enfermedades o medicamentos. Su causa principal es el estilo de vida no …
Nuevos enfoques terapéuticos de las dislipidemias
IO Armas, AE Lara, SNG Benítez… - … Científico Médico de …, 2020 - medigraphic.com
La dislipidemia es un factor de riesgo importante modificable de enfermedad cardiovascular
por aterosclerosis. Se realizó una revisión bibliográfica con los descriptores dislipidemia y …
por aterosclerosis. Se realizó una revisión bibliográfica con los descriptores dislipidemia y …
[HTML][HTML] Hipertrigliceridemia: clasificación, riesgo cardiovascular y conducta terapéutica
SN González Benítez, GE Feria Díaz… - Correo Científico …, 2020 - scielo.sld.cu
La hipertrigliceridemia es una afección común, debida a alteraciones genéticas o primarias
y secundarias a enfermedades o medicamentos. Su causa principal es el estilo de vida no …
y secundarias a enfermedades o medicamentos. Su causa principal es el estilo de vida no …
Novel therapeutics in hypertriglyceridaemia and chylomicronaemia
JDG Díaz - Medicina Clínica (English Edition), 2020 - Elsevier
Currently there is evidence on hypertriglyceridaemia as an independent risk factor of
atherosclerosis. Chylomicronaemia associated with very high concentration of triglycerides …
atherosclerosis. Chylomicronaemia associated with very high concentration of triglycerides …